Blue Cross Blue Shield · CPAP APAP · US health-plan appeal rights

CPAP APAP denied as experimental or investigational by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield CPAP APAP denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

An experimental denial requires the appeal to cite the FDA approval (if any), peer-reviewed phase III data, and the recognised specialty-society guideline that supports the treatment for your indication.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-11

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Anthem BCBS clinical guideline (PAP) + the applicable clinical guideline (Polysomnography) + the applicable clinical guideline (HGNS)

The Blue Cross Blue Shield angle on CPAP APAP

## Why BCBS Denied Your CPAP/APAP as Experimental or Investigational

An experimental or investigational denial for a CPAP or APAP device is uncommon but can occur in specific contexts: when coverage is sought for a newer device feature, an advanced titration mode, a combination therapy attachment (such as a heated humidifier with specific functionality), or a use outside the standard obstructive sleep apnea indication — for example, application to central sleep apnea or a complex breathing disorder. BCBS may also apply this classification if its internal medical policy has not yet been updated to reflect a recently cleared device variant.

These denials are appealable, particularly because CPAP and APAP are FDA-cleared, widely used, and supported by well-established clinical evidence and sleep medicine society guidelines for the treatment of obstructive sleep apnea. If the denial reflects a gap in BCBS's policy rather than a genuine evidentiary deficiency, this argument should be made directly in the appeal.

## Your Federal Appeal Rights

Internal appeal (ACA §2719 / ERISA §503): You have the right to a written internal appeal within the timeframe on your denial notice — typically 180 days.
External review: After a final internal denial, you may request independent external review within approximately four months. An independent review organization (IRO) will evaluate whether the experimental classification is appropriate. IRO decisions bind the plan.
Expedited review: If your health would be seriously jeopardized by waiting, expedited internal review (typically 72 hours) and expedited external review are available.

## How to Build Your Appeal

1. Confirm FDA clearance status for the specific device and indication. Obtain documentation of the FDA 510(k) clearance (or equivalent) for the exact device model and the indication for which it is being prescribed. If the device is cleared for your indication, the experimental classification may be erroneous and should be challenged directly.

2. Request the BCBS medical policy used to deny coverage. You are entitled to receive the specific policy that was applied. Review it carefully for: the evidentiary standard used to define experimental; any carve-outs for FDA-cleared devices; and the criteria for an exception.

3. Build a criterion-by-criterion response. Copy each policy criterion into your appeal and respond with chart-based facts and, where applicable, references to your prescriber's letter and applicable clinical guidelines.

4. Obtain a prescriber letter addressing the experimental classification directly. The letter should: confirm the diagnosis (typically obstructive or complex sleep apnea) with supporting diagnostic study results; explain why the specific device or mode is clinically indicated; note that the treatment is consistent with applicable sleep medicine society guidelines (e.g., from the American Academy of Sleep Medicine), referencing the organization generically; and address the experimental criterion specifically.

5. Include objective diagnostic documentation. Sleep study results confirming the diagnosis, severity documentation, and prior treatment history (including any prior PAP trial outcomes) all support the appeal.

## Timeline

File the internal appeal within the window on your denial notice.
After a final internal denial, request external review within approximately four months.

DenialHelp can help you map the FDA clearance documentation and clinical evidence against BCBS's policy criteria to build a focused, structured appeal.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other insurers on CPAP APAP

Other denial reasons for Blue Cross Blue Shield CPAP APAP

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-11. Editorial standards: denialhelp.com/authors.